Sutro Biopharma, Inc. (STRO)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
STRO price, last 12 months
Key stats
- Previous close
- $15.71
- Open
- $15.71
- Day range
- $14.95 – $16.19
- 52-week range
- $7.15 – $43.85
- Volume
- 255.8K
- Avg volume (20 days)
- 322.9K
- Market cap
- $265.0M
Performance
Technicals and fundamentals
About Sutro Biopharma, Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $265.0M